Kriegbaum N J, von Linstow M, Oxholm P, Prause J U
Department of Rheumatology TTA, Rigshospitalet, Denmark.
Acta Ophthalmol (Copenh). 1988 Oct;66(5):481-4. doi: 10.1111/j.1755-3768.1988.tb04367.x.
Thirty-four patients, all fulfilling the Copenhagen criteria for Primary Sjögren's Syndrome, were examined retrospectively in order to evaluate possible longitudinal alterations in Schirmer-1-test results, Rose-bengal score, break-up time and level of ocular score. Twenty-three of the patients were characterized as Bromhexine responders according to their initially positive response to systemic treatment (16 mg x 3 daily) and 11 patients were Bromhexine non-responders. All patients were treated with tear substitutes during the entire observation period of 27 to 76 months (mean 53 months), and all eye examinations were carried out by the same ophthalmologist. The responder group had, both in the start as well as at the end of the observation period, a better ocular status compared to the non-responder group. The latter group had a significantly (P less than 0.02) lower Schirmer-1-test at the start and at the end of the period, and a significantly (P less than 0.02) higher Rose-bengal score at the end of the period. Moreover, the responder group improved in Rose-bengal score (P less than 0.001), whereas the non-responder group improved both in break-up time (P less than 0.05) and Rose-bengal score (P less than 0.05). The use of a score combining results from all three tests, i.e. the ocular score, seems to be a useful tool when evaluating longitudinal variations i dry eye states. Considerable variation was seen between successive results of each ocular test, also in the periods without systemic treatment.
对34例均符合原发性干燥综合征哥本哈根标准的患者进行回顾性研究,以评估泪液分泌试验-1(Schirmer-1-test)结果、孟加拉玫瑰红评分、泪膜破裂时间及眼表评分可能的纵向变化。根据对全身治疗(每日3次,每次16mg)的初始阳性反应,23例患者被归类为氨溴索反应者,11例患者为氨溴索无反应者。在27至76个月(平均53个月)的整个观察期内,所有患者均接受泪液替代治疗,所有眼科检查均由同一位眼科医生进行。与无反应组相比,反应组在观察期开始和结束时的眼部状况均更好。无反应组在观察期开始和结束时的泪液分泌试验-1结果显著更低(P<0.02),在观察期末的孟加拉玫瑰红评分显著更高(P<0.02)。此外,反应组的孟加拉玫瑰红评分有所改善(P<0.001),而无反应组在泪膜破裂时间(P<0.05)和孟加拉玫瑰红评分(P<0.05)方面均有所改善。使用结合所有三项检查结果的评分,即眼表评分,在评估干眼状态的纵向变化时似乎是一个有用的工具。在每次眼表检查的连续结果之间,即使在没有全身治疗的期间,也观察到了相当大的差异。